本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盤後16.910.00000.00%16:40 EDT
成交量:142.87萬
成交額:2,410.12萬
市值:17.78億
市盈率:-11.68
高:17.30
開:16.64
低:16.05
收:16.68
資料載入中...
2021/11/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/13

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/22

SEC問詢函

CORRESP [Cover] - Correspondence